COYA COYA THERAPEUTICS INC

2026Q2 · CUSIP 22407B108 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it

Institutions that reported holding it to the SEC

Net decrease in holders

Last quarter 56 → now 55

How unusual is that

Below average

Stronger than only 32% of US stocks

What the filings say, in one paragraph

55 funds held COYA at the end of 2026Q2, down 1 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $8M(YoY +1793.8%), return on equity is -50.1%. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

What happened after each past buying rush

This stock has never had a buying rush

Show all the numbers (large funds, value held, options…) ▾

Of them, large funds

Change in large funds

Total value they hold

$45M

Funds buying for the first time

Funds that sold out entirely

Price change that quarter

—

Funds holding puts (bearish)

Funds holding calls (bullish)

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)

—

EPS (TTM)

$-1.07

EPS YoY

—

Revenue (TTM)

$0.0B

Revenue YoY

+1793.8%

Net margin

-270.2%

ROE

-50.1%

Debt ratio

8.5%

FCF (TTM)

—

Dividend (TTM)

No dividend

Quarterly Revenue & EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.